Launch management

eGO

Pharmaceutical Launch Management Platform

Know whether every product, SKU and country is ready—and permitted—to launch.

eGO connects internal process readiness with external market-entry limits. PATEX, MA and DA dates become visible, controlled inputs to every launch plan—continuously checked against target and forecast dates from the first launch wave to Go / No-Go, market entry and stabilisation.

Part of the e-line product family
eGO Launch Portfolio dashboard with readiness, launch dates and market health
At a glance

eGO quick overview

Best for
Launch excellence, regulatory, supply, commercial, quality and local affiliate teams
Replaces
Disconnected launch plans, market-limit trackers, country status decks and manual readiness reporting
Core outcome
Evidence-based confidence that each product and SKU is both ready and permitted to launch in each market
Deployment
Customer infrastructure or managed environment; supports standalone use and e-line integrations
Compliance
Controlled workflows, permissions, audit history and traceable decision evidence; validation support available
Licensing
Flexible licensing not tied to the number of users
Key capabilities
  • PATEX, MA and DA limit control
  • Project scope and launch waves
  • Country and SKU readiness
  • Go / No-Go governance
Readiness meets market reality

A launch date is only credible when the organisation is ready and the market is open

Pharmaceutical launches depend on Regulatory, Supply, Quality, Packaging, Market Access, Medical, Commercial and local affiliate teams moving together. They also depend on external limits such as PATEX, MA and DA. When these two realities live in separate trackers, a launch can look operationally ready while its planned date is still impossible.

eGO creates one shared control picture: what is launching, where and when; what each team must complete; which external limit controls market entry; and whether target and forecast dates remain compliant. Conflicts are made visible across the portfolio and carried into accountable Go, Conditional Go, Hold or No-Go decisions.

Disconnected country launch plans, functional trackers, SKU scope and evidence consolidated into eGO Launch Readiness

What eGO helps you manage

One launch management environment for internal readiness, external market-entry control and evidence-based decisions.

Launch Templates & Operating Model

Standardize launch types through reusable areas, weighted requirements, blocking and evidence rules, due-date offsets, geographic applicability and RACI owner presets.

Launch Portfolio & Waves

Structure launch initiatives into coordinated waves and market launches, with clear dates, health, priority and ownership.

Country & SKU Scope

Define exactly which products, packs and local SKUs will launch in each country, including local names, GTINs and artwork references.

External Market-Entry Limits

Capture PATEX, MA and DA limits by product and market, calculate the earliest permitted market entry and keep every launch plan aligned with the current external constraint landscape.

Readiness Management

Apply the right template to each market launch, assign requirements and calculate readiness from weighted, evidence-based progress.

Milestones & Dependencies

Connect regulatory, supply, quality, market access, medical and commercial activities so delays and critical-path impact become visible early.

Go / No-Go Governance

Prepare a complete decision package and record Go, Conditional Go, Hold or No-Go decisions with conditions and accountable owners.

Exceptions & Action Control

Bring blockers, risks, overdue requirements, escalations and corrective work into one controlled operational view.

Documents & Launch Evidence

Keep versioned documents, approvals and evidence linked to the requirement, gate and market launch they support.

Executive Insights

Connect readiness and launch risk with forecast revenue, investment, probability of success and portfolio value at risk.

Roles, RACI & My Work

Give launch managers, local leads and functional owners a clear view of responsibility, workload, due dates and missing coverage.

AI Smart Actions

Run advisory readiness, date-risk, completeness, change-impact and portfolio reviews without changing controlled process data.

From portfolio intent to launch confidence

eGO keeps every level connected—from launch initiative and wave to country, SKU, PATEX/MA/DA limits, readiness requirements and decision evidence.

01

Define the product-to-market scope before planning the launch

Start with the approved project, its products, registered products and packagings. The Scope Matrix determines which exact packaging belongs to which country, creating a controlled foundation for launch creation and preventing invalid local SKU scope later in the process.

02

Build the external market-entry landscape once

Capture PATEX, MA and DA limits as governed, country-specific records instead of copying dates between launch trackers. eGO keeps the protection type, territory, effective date, legal status, confidence, source, verification and review history together, with efficient entry across multiple markets.

03

Turn the launch operating model into reusable templates

Launch Templates are the backbone of consistent readiness. Configure applicability by launch type and geography, define functional areas and requirements, set criticality, weight, blocking and evidence rules, calculate due dates from the target launch date and preset RACI owners and deputies.

04

Create the initiative, first wave and market launches together

The New Launch wizard converts approved project scope into an executable launch structure. Select products and target markets, define the initiative and first wave, choose the launch type and target date, and apply the correct readiness template as the market launches are created.

05

Coordinate waves and markets from the launch initiative

The Launch Initiative detail keeps strategy, product scope, waves, countries and the resulting market launches together. Launch managers can understand sequencing across markets while each country remains an independently governed execution unit.

06

Control the full country launch from one detail

Market Launch Detail is the operational system of record. Its Overview brings product, country, local pack scope, ownership and launch dates together with the applicable external limits, earliest permitted market entry and a clear conflict status before teams move into readiness and governance execution.

07

Turn external limits into enforceable launch guardrails

For every market launch, eGO determines which protections apply, identifies the controlling constraint and calculates the legal earliest launch date with safety buffers and local waiting periods. Target and forecast dates are checked automatically; conflicts and stale reviews remain visible from the individual assessment to the portfolio-wide External Constraints cockpit.

08

Execute readiness by function and prove every result

The applied template becomes a versioned readiness snapshot for the market. Functional owners update requirements, resolve blockers and attach text, URL or approved-document evidence. Weighted scoring and critical rules then drive the launch health seen across the portfolio.

09

Manage dates, dependencies, risks and baseline changes

Milestones and dependencies make schedule impact explicit, while Actions & Risks turn exceptions into owned work. Target and forecast dates are continuously checked against approved PATEX, MA and DA limits; a conflicting date is blocked unless it follows a controlled launch-at-risk route. Material baseline changes remain traceable through change control.

10

Make an evidence-based Go / No-Go decision

Decision Package brings operational readiness together with the external market-access assessment: the legal earliest launch date, controlling constraint, unresolved impacts and any date conflict sit alongside evidence, exceptions, milestones and business context. Approvers can record Go, Conditional Go, Hold or No-Go with full rationale and history.

11

Preserve launch evidence and close with a complete history

Documents move through versioning and approval workflows and approved versions can become readiness evidence. After launch, teams record the actual outcome, lessons learned and handover; closure locks operational editing while keeping the complete activity and decision history available.

12

Run the portfolio by exception and business impact

Launch Portfolio and Control Center surface delayed markets, overdue requirements, external-limit conflicts, overdue reviews, upcoming gates and missing owners. The same market-entry status follows each launch through product, project and executive views, so management can focus on the launches where intervention and value are most at risk.

nData e-line

Launch orchestration across the e-line ecosystem

eGO owns launch readiness, external market-entry control and market launch decisions while connecting the work around them: portfolio priorities from ePM, regulatory status from eRA, approved artwork from eAW, controlled documents from eDOCS and quality or laboratory evidence from specialized systems.

eGO turns connected domain evidence into one coherent answer: are we ready and permitted to launch?

ePM
eRA
eGO
eTRANSFER
eAW

Artwork execution follows regulatory and launch change context.

Supporting systems across the lifecycle
eDOCSeQCPeLABeTMF

Typical use cases

Answer the operational and governance questions behind every successful market launch.

Launch portfolio steering

  • Which launches are on track, delayed or at risk?
  • Which waves and markets need management attention?
  • Where is the greatest revenue or value at risk?
  • How has portfolio readiness changed over time?

Market launch execution

  • Is this product and SKU ready for this country?
  • Do PATEX, MA or DA set a later market-entry date?
  • Which functional requirements are incomplete or blocked?
  • Who owns the next action and when is it due?
  • Which dependency threatens the committed launch date?

Governance & decision readiness

  • Do we have enough evidence to make a Go decision?
  • Is the launch date compatible with approved external limits?
  • Which critical exceptions remain unresolved?
  • Can we proceed conditionally, and under what conditions?
  • Is the decision and its rationale fully traceable?

Cross-functional coordination

  • Are Regulatory, Supply, Quality and Commercial aligned?
  • Are all requirements covered by an accountable owner?
  • What is overdue in each team or local affiliate?
  • What changed against the approved baseline?
AI Smart Actions

Focused launch insight, always under human control

Optional Smart Actions review launch readiness, Go / No-Go inputs, date risk, completeness, exceptions, change impact and portfolio risk. Each analysis uses the selected launch context, returns structured findings for review and never changes controlled process data or replaces accountable decisions.

PortfolioInitiativeWaveMarket LaunchExternal LimitsReadiness
Example smart actions
More contextual actions across launch planning, readiness and governance views.
ScopePATEX / MA / DARequirementsEvidenceDependenciesExceptions
Launch Readiness Review resultExample output generated for a specific eGO market launch.
Contextual AI Smart Actions
Built for launch reality

One controlled path from market limits to stabilisation

eGO reflects how pharmaceutical launches actually work: global initiatives become launch waves, waves become country launches, and every market has its own PATEX, MA and DA limits alongside SKU scope, owners, readiness evidence, dependencies, risks and decision history.

Portfolio ScopeExternal LimitsLaunch WavesMarket ReadinessGo / No-GoMarket LaunchStabilisation & Closure
Benefits

What eGO helps you achieve

One current view of operational readiness and external market-entry eligibility across initiatives, waves, markets and SKUs
PATEX, MA and DA limits visible wherever launch dates are planned, reviewed or approved
Earlier visibility of blockers, dependencies and forecast date risk
Consistent readiness standards through reusable, market-aware templates
Clear accountability across global functions, local affiliates and governance teams
Evidence-based Go / No-Go decisions covering both internal readiness and external constraints
Stronger connection between operational readiness, investment and portfolio value
Less manual reporting and fewer disconnected country launch trackers
Controlled baselines, change requests, approvals and audit history
Request a demo

Turn readiness and market limits into launch confidence

See how eGO can connect PATEX, MA and DA limits with country scope, functional readiness, evidence, dependencies and governance across your pharmaceutical launch portfolio.

Request a Demo